Pralmorelin
Pralmorelin
Pralmorelin (pronounced pral-mor-eh-lin), also known as GHRP-2 or Growth Hormone Releasing Peptide 2, is a synthetic hexapeptide that stimulates the release of growth hormone from the pituitary gland. It is a ghrelin analogue and one of several synthetic met-enkephalin analogues that include unnatural D-amino acids, developed for their growth hormone releasing properties.
Etymology
The term "Pralmorelin" is derived from the combination of the words "pral" and "morelin". "Pral" is a prefix used in the pharmaceutical industry to denote synthetic drugs, while "morelin" is derived from "more", indicating an increase or enhancement, and "relin", a common suffix in endocrinology, referring to hormone release.
Usage
Pralmorelin is used in the diagnosis of growth hormone deficiency and is also being studied for its potential to promote weight loss in obese individuals. It is administered through subcutaneous injection.
Related Terms
- Growth Hormone (GH): A peptide hormone that stimulates growth, cell reproduction, and cell regeneration in humans and other animals.
- Pituitary Gland: A small pea-sized gland that plays a major role in regulating vital body functions and general wellbeing.
- Ghrelin: A hormone produced by enteroendocrine cells of the gastrointestinal tract, especially the stomach, and often called a "hunger hormone" because it increases food intake.
- Growth Hormone Deficiency (GHD): A medical condition, due to problems arising in the pituitary gland, in which the body does not produce enough growth hormone.
External links
- Medical encyclopedia article on Pralmorelin
- Wikipedia's article - Pralmorelin
This WikiMD dictionary article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski